Skip to content

Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding

Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03351673
Enrollment
100
Registered
2017-11-24
Start date
2017-08-08
Completion date
2018-08-31
Last updated
2017-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial Disorder

Brief summary

Endometrial thickness has been used as an indicator of risk for endometrial hyperplasia and carcinoma in asymptomatic perimenopausal women. However, there is no cutoff value in perimenopausal women and the same thickness does not express the same endometrial volume in different endometrium because uterine lengths may be different and endometrial irregularities may exist. Many studies assessed endometrial volume measured by three-dimensional (3D) TVS as a predictor of malignancy in women with postmenopausal bleeding. To our knowledge there is no study assess endometrial volume measured by two dimension TVS in prediction of endometrial pathology, however it is cheap and available than 3D TVS.

Interventions

DIAGNOSTIC_TESTendometrial volume 2D TVS

calculation the endometrial volume using 2D ultrasound and correlation the results with the pathological findings of endometrial biopsy

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

\*perimenopausal women with abnormal bleeding e.g. menorrhagia, metrorrhagia and polymenorrhea.

Exclusion criteria

\*general or local causes of bleeding, drug intake or recent hormonal contraception

Design outcomes

Primary

MeasureTime frame
accuracy of measurement of endometrial volume by 2D TVS in prediction of endometrial pathology1year

Countries

Egypt

Contacts

Primary ContactHanan Nabil, MD
hanannobil00@yahoo.com002/01000571004
Backup ContactWaleed Elrefaie, MD
wrefaie@yahoo.com002/01224515318

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026